65,437 trials
Hemianopia · Hemianopsia · Peripheral Visual Field Defect
Primary: Number of Collision Incidents (All Contacts) — 13.79; 9.26 Rate (contacts per 100 hazards per hour) — p=< 0.001
Pharmacodynamics · Obesity
Primary: Dose of Propofol That Caused Loss of Consciousness in 95% (ED95) of Obese and Non-obese Children — 2; 2.125 mg/kg
Hypoxia · Endoscopy · Anesthesia Morbidity
Primary: Hypoxia Rate as Assessed by Number of Participants With at Least One Hypoxic Event — 3; 16 Participants
Ulcerative Colitis · Crohn's Disease
Primary: AUCWeek 14: Area Under the Serum Concentration-time Curve at Week 14 — 1933.5076; 3231.1001; 2344.4204; 3091.7957 h*ng/mL
HIV Infections · Tuberculosis
Primary: Number of Participants Who Permanently Discontinued Treatment Due to Adverse Event(s) of Greater Than or Equal to Grade 3 Deemed at Least Possibly Related to Raltegravir…
Breast Neoplasms
Primary: Progression Free Survival (PFS) — 3.5; 7.2; 5.6 months — p=0.537
Healthy · Chronic Illnesses, Multiple
Primary: Knowledge Scores at 1 Week — 35.32; 36.93 units on a scale — p=<.25
Ovarian Cancer · Neoplasms · Carcinoma
Primary: Progression-free Survival for at Least 6 Months (PFS-6) — 10 Percentage of participants
Diarrhea · Diarrhea Rotavirus
Primary: Geometric Mean Concentration Using WC3 as the Viral Lysate — 18.1; 14.0 U/ml
Pertussis
Primary: Number of Participants With Known Pregnancy Outcomes, by Type of Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Boostrix During Pregnancy…
Advanced Cancer · Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
Primary: Number of Participants Who Experienced Dose-Limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
End Stage Renal Disease
Primary: Reduction Ratio of Lambda Immunoglobulin FLC at Week 24 — 32.156; 17.514 percentage ratio
Ulcerative Colitis
Primary: Number of Subjects With Serious and Non-serious Adverse Events. — 0; 0; 0 Participants
Total Hip Arthroplasty
Primary: Change in Bone Mineral Density — 1072; 1295 number of pixels with change
Acne Scars
Primary: Severity Change in Acne Scarring — -2 score on a scale